Nagaraju Anreddy

<i>In vitro</i>, <i>in vivo</i> and <i>ex vivo</i> characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter <scp>MRP1</scp>

Hui Zhang, Atish Patel, Shaolin Ma et al. · British Journal of Pharmacology · 2014 · 52 citations · Full text

PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR

Nagaraju Anreddy, Atish Patel, Kamlesh Sodani et al. · Acta Pharmaceutica Sinica B · 2014 · 51 citations · Full text

Exploring naturally occurring ivy nanoparticles as an alternative biomaterial

Yujian Huang, Yi‐Jun Wang, Yongzhong Wang et al. · Acta Biomaterialia · 2015 · 49 citations

Nanoparticles, Engineering, Nanobiotechnology +5

Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo

Kamlesh Sodani, Atish Patel, Nagaraju Anreddy et al. · Biochemical Pharmacology · 2014 · 47 citations · Full text

Molecular Pharmacology, Drug Targeting, Novel Therapy +9

PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells

Atish Patel, Amit K. Tiwari, Eduardo E. Chufán et al. · Cancer Chemotherapy and Pharmacology · 2013 · 46 citations · Full text

Abcb1-mediated Drug Resistance, Selective Fgfr Inhibitor, Medicine +6